Boehringer Ingelheim announces plans to advance potential new treatment for Geographic Atrophy, following positive Phase I results 5-09-2024, 21:52

Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically Meaningful Benefit for Patients With PSMA-Positive Metastatic Castration Resistant Prostate Cancer 13-11-2024, 22:57

Bitget Amplifies Global Leadership and Community Impact with Strong Presence at TOKEN2049 Dubai 5-05-2025, 09:33